Economy misquarters and weaker sales and potential ebola outbreak. Sales are back. It is mixed, with the dow sinking and the nasdaq gaining, they help consolidate the gains from last weeks rally. Now, the two deals we had today were typical of what were seeing before at least the pause in october. Lab clinical Testing Company that tests new drugs is a logical Extension Company for one thats tapped out for growth. It rivals letter q, my favorite, and par xl which has a terrible quarter. This deal rekindles the things going on in the health care space. The companies cant keep to help but merge. You know what . I would take the 25 gain and run. Sell, sell, sell. Its the other deal. The french advertisie ining fir buying sabian. We have to drill it down here. When i read about this, i was a bit mystified. I knew sapient as a smaller scale sape. The division called sapient nitro. While the publicist was nicked, i can see the synergies and recognize how it can make publicists relevant in the
Allsup Healthcare Insurance Services experts discuss workforce trend with more Medicare-age workers waiting to retire during DMEC event, register online.